+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Yiqing Keli Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 196 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6128050
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Yiqing Keli Market grew from USD 102.15 million in 2025 to USD 110.40 million in 2026. It is expected to continue growing at a CAGR of 7.11%, reaching USD 165.28 million by 2032.

Setting the Stage for Yiqing Keli: How Consumer Trust, Quality Signals, and Modern Wellness Behaviors Are Redefining the Category

Yiqing Keli sits at the intersection of modern consumer health expectations and long-standing herbal practice, making it a category where trust, traceability, and tangible outcomes matter as much as brand storytelling. Across many markets, buyers are more deliberate: they read labels closely, compare formats for convenience, and expect consistent quality supported by credible manufacturing controls. At the same time, retailers and digital platforms are tightening standards around claims, ingredient provenance, and safety documentation, raising the bar for everyone competing in the space.

Against this backdrop, Yiqing Keli is increasingly shaped by a dual demand curve. On one side are tradition-oriented users who value heritage, recognizable botanical profiles, and familiar preparation rituals. On the other are lifestyle-driven consumers who prioritize portability, taste, and fit with daily routines, and who often discover products through social commerce, influencer education, and search-led shopping. This mix is pushing brands to professionalize messaging, strengthen quality systems, and engineer products that deliver a reliable experience at scale.

Furthermore, competition is no longer limited to adjacent herbal products. Functional beverages, condition-specific nutraceuticals, and wellness bundles are encroaching on the same consumer intent. As a result, success depends on crisp positioning, evidence-aligned communication, and operational excellence across sourcing, manufacturing, and distribution. This executive summary frames the most important shifts, tariff-related implications, segmentation and regional dynamics, and strategic actions that can help decision-makers compete more effectively.

Transformative Shifts Reshaping Yiqing Keli: Quality Upgrades, Digital-First Discovery, Format Innovation, and Resilience-Driven Operations

The competitive landscape for Yiqing Keli is undergoing a structural upgrade as quality assurance becomes a primary differentiator rather than a baseline expectation. Manufacturers are investing more heavily in standardized processing, contaminant controls, and documentation practices that can withstand retailer audits and cross-border scrutiny. This shift is also changing how brands talk about products: messaging is moving toward clearer usage guidance, more transparent ingredient sourcing narratives, and a more disciplined approach to structure/function language.

In parallel, the channel environment is being reshaped by the continued maturation of digital commerce. Search-driven discovery and short-form education have amplified the importance of packaging readability, product photography, and fast answers to consumer questions. Brands that treat their product detail pages as living clinical-style dossiers-while remaining compliant-are improving conversion and reducing returns. Meanwhile, offline retail is responding with tighter assortment logic, placing more emphasis on dependable replenishment, fewer but stronger SKUs, and supplier responsiveness.

Another transformative shift involves product engineering and format innovation. Consumers increasingly reward products that reduce preparation friction, improve taste experience, and maintain stability across shipping conditions. That reality is accelerating investments in granule consistency, dissolution performance, packaging that protects against moisture, and portion control that supports routine adherence. As the category professionalizes, the winners are likely to be those that treat formulation, manufacturing, and brand education as one integrated system rather than separate functions.

Finally, the landscape is being influenced by geopolitics and supply-chain risk management. Businesses are diversifying supplier bases, adjusting inventory strategies, and building dual-sourcing options for critical inputs. This is not only a resilience play; it is becoming a growth lever as brands that can maintain continuity during disruptions earn greater retailer confidence and capture share of consumer mind.

Understanding the 2025 United States Tariff Ripple Effects: Cost Structures, Sourcing Decisions, Compliance Burden, and Portfolio Prioritization

United States tariff dynamics in 2025 are reinforcing a broader reality for Yiqing Keli: landed cost volatility can quickly become a brand and channel issue, not just a procurement problem. When tariffs apply to certain imported inputs, packaging components, or finished goods classifications, the impact often shows up first in margin compression. Companies then face a set of difficult choices-raise prices, reconfigure pack sizes, shift promotional cadence, or absorb costs while hoping to protect velocity.

In practice, the cumulative effect is most pronounced where supply chains are linear and concentrated. Businesses relying heavily on single-country sourcing for key botanicals or on a narrow set of co-manufacturing partners may experience more abrupt cost swings and longer lead times. Over time, this can reshape assortment decisions as retailers favor suppliers who can keep fill rates stable and avoid frequent price changes. For digital channels, where price comparison is frictionless, tariff-driven pricing shifts can erode conversion unless they are offset by stronger value communication or differentiated bundling.

Tariffs also influence compliance and documentation behavior. As firms explore alternative sourcing routes or processing locations, they must maintain consistent quality specifications and auditable records across the chain of custody. This increases the operational premium on supplier qualification, incoming inspection, and batch-level traceability. In effect, tariff pressure is accelerating modernization: businesses that build a resilient supply network with verified equivalence across sources are better positioned to maintain consumer trust and channel relationships.

Looking ahead, tariff uncertainty is likely to remain a recurring feature of strategic planning. The most effective responses are not reactive price moves but structural actions such as packaging optimization, smarter inventory segmentation, selective nearshoring of certain steps, and portfolio rationalization that concentrates investment behind the SKUs with the clearest consumer pull and the strongest operational economics.

Key Segmentation Insights for Yiqing Keli: How Form, Channel, Use-Case Intent, and Price Positioning Drive Differentiated Winning Plays

Segmentation in Yiqing Keli clarifies where growth-quality demand is forming and where operational friction can undermine performance. When viewed by product form, the category often divides into options optimized for ritual preparation versus options designed for speed and portability, with the latter typically benefiting from modern lifestyle routines and on-the-go usage occasions. This distinction matters because it changes what consumers perceive as quality: consistency of granules, dissolution behavior, flavor masking, and packaging integrity become as important as the botanical profile itself.

When examined through the lens of distribution channel, the path to purchase diverges sharply between pharmacy-led credibility, specialty retail education, and digital marketplaces that reward search relevance and review momentum. Online, the winners tend to be brands that communicate usage clarity, quality assurances, and authentic provenance in a concise, mobile-friendly way. In offline settings, trained staff influence outcomes, and product packaging must communicate quickly while aligning with retailer compliance expectations. As a result, companies that tailor content, pack architecture, and replenishment discipline to each channel typically sustain stronger repeat.

Segmentation by application and consumer intent further reveals how brands should prioritize communication. Buyers seeking everyday wellness support often respond to gentle, routine-friendly narratives and palatable formats, while those who shop with more specific outcomes in mind demand clearer guidance on timing, contraindications, and compatibility with other wellness regimens. Consequently, brands that map use-cases to practical education-without overstepping regulatory boundaries-build trust and reduce churn.

Finally, segmentation by end user and price positioning underscores the importance of tiered portfolios. Premium offerings can justify their place through traceability, tighter quality controls, and upgraded sensory experience, while value-oriented products win when they deliver dependable consistency and accessible preparation. Across segments, the strategic throughline is the same: the more precisely a company aligns product experience, documentation, and messaging to the segment’s decision drivers, the more resilient it becomes against both competitive noise and cost shocks.

Key Regional Insights Across the Americas, Europe, Middle East & Africa, and Asia-Pacific: Localization, Compliance, and Channel Power Dynamics

Regional dynamics in Yiqing Keli reflect differences in regulatory expectations, retail structures, and cultural familiarity with herbal formats. In the Americas, demand is increasingly shaped by label scrutiny, retailer compliance requirements, and the rise of digital-first buying. This environment favors brands that can translate traditional concepts into clear, responsible language while maintaining robust documentation, consistent quality, and dependable delivery performance. Tariff sensitivity and cross-border logistics also elevate the importance of supply-chain design and transparent provenance.

Across Europe, the competitive edge often hinges on navigating varied country-level expectations around herbal products, claims boundaries, and quality standards. Companies that invest in compliant localization-packaging language, usage guidance, and documentation tailored to national norms-tend to earn stronger distribution continuity. In addition, pharmacy and specialist channels can play a more pronounced role in shaping credibility, making professional-grade presentation and traceable sourcing especially valuable.

In the Middle East and parts of Africa, channel development and consumer education can be decisive. Where modern trade and e-commerce are expanding, there is room for brands that combine accessibility with reassurance on quality, authenticity, and safe use. Partnerships with capable distributors, stable warehousing practices, and packaging engineered for heat and humidity can materially improve consumer experience and reduce operational losses.

The Asia-Pacific region remains pivotal due to deep consumer familiarity and dense competitive ecosystems. However, competition here is not only about heritage; it is increasingly about manufacturing sophistication, brand differentiation, and omnichannel execution. Companies that refine sensory experience, reduce preparation friction, and reinforce trust through visible quality signals are better positioned to compete in both mature and rapidly digitizing markets. Across regions, the consistent pattern is that localization is no longer optional: it is the mechanism through which quality, compliance, and consumer relevance become scalable.

Key Company Insights in Yiqing Keli: Operational Quality Moats, Portfolio Discipline, Education-Led Branding, and Omnichannel Execution Excellence

Company performance in Yiqing Keli increasingly clusters around a few core capabilities: secured access to high-quality botanical inputs, repeatable manufacturing consistency, and an ability to communicate value without triggering compliance risk. Leading players are placing greater emphasis on supplier qualification programs, batch-level traceability, and process controls that reduce variability in taste, texture, and dissolution. These operational strengths translate directly into brand outcomes because consumers use consistency as a proxy for trust.

Another differentiator is portfolio architecture. Strong competitors rationalize SKUs to protect focus, then build deliberate ladders that address both heritage-oriented buyers and convenience-first adopters. This often includes thoughtful pack-size strategies, channel-specific assortments, and limited but meaningful format extensions that improve everyday usability. Companies that expand too broadly without operational discipline can struggle with inventory complexity and uneven quality signals.

Commercially, the most effective companies treat education as a product feature. They invest in packaging hierarchy, clear usage narratives, and training assets that help retail staff and digital customer service teams answer common questions. At the same time, they cultivate review quality and post-purchase guidance, recognizing that repeat is driven by informed use and managed expectations. As competition intensifies, the companies that pair rigorous quality systems with persuasive, compliant storytelling are the ones most likely to earn durable loyalty.

Actionable Recommendations for Industry Leaders: Resilient Sourcing, Compliance-Safe Storytelling, Portfolio Focus, and Experience-Driven Product Excellence

Industry leaders can strengthen their position by treating resilience and differentiation as one agenda. Start with a supply-chain redesign that identifies tariff exposure, single-point dependencies, and ingredient criticality, then build dual-sourcing and equivalency protocols that preserve product consistency. In parallel, tighten specifications for sensory experience and performance-in-use, because consumers judge quality through what they can feel: taste, texture, dissolution, and the reliability of results over time.

Next, elevate compliance-forward storytelling. Replace vague claims with clear usage guidance, transparent sourcing narratives, and documentation-backed quality signals that can be expressed on-pack and online. Strengthen product pages with plain-language explanations of what the product is, how it is used, what quality controls are applied, and what to expect. This not only supports conversion but also reduces misuse and dissatisfaction.

Then, optimize portfolios by segment role rather than internal convenience. Concentrate resources behind hero SKUs with strong repeat economics, and ensure channel assortments reflect how each channel sells and educates. For digital, focus on discoverability and review health; for offline, prioritize packaging clarity, staff enablement, and replenishment performance. Finally, invest in feedback loops-post-purchase education, customer support scripts, and quality monitoring-to convert first-time trial into habitual use while catching variability early.

Taken together, these moves help companies protect margins under cost volatility, earn retailer trust through operational reliability, and build brand equity through consistent product experience and responsible communication.

Research Methodology Built for Decision-Makers: Triangulated Primary Inputs, Structured Secondary Review, and Practical Synthesis for Strategy

This research methodology integrates primary and secondary approaches to build a decision-oriented view of the Yiqing Keli landscape. The process begins by establishing a clear market definition, mapping product forms, use contexts, and channel pathways, and then aligning these elements to a structured segmentation framework. This ensures that insights are comparable across competitors and regions while remaining grounded in how products are actually bought, used, and regulated.

Secondary research includes a systematic review of public materials such as company disclosures, product labels, channel listings, regulatory guidance, trade publications, and industry conference materials. This is complemented by structured tracking of pricing architectures, pack formats, promotional patterns, and messaging conventions across major retail and digital environments. The goal is to understand not only what is being sold but also how value is being communicated and what operational signals-such as availability, consistency, and documentation-appear to shape purchase decisions.

Primary research emphasizes direct engagement with knowledgeable stakeholders across the value chain, including manufacturers, distributors, retailers, and subject-matter experts. Interviews are designed to test hypotheses, clarify procurement and quality practices, and identify emerging shifts in consumer preferences and channel requirements. Findings are triangulated to reduce bias, and conflicting inputs are resolved through follow-up validation and cross-checking against observable channel behavior.

Finally, insights are synthesized into thematic frameworks covering competitive strategy, segmentation drivers, regional dynamics, and risk factors such as tariff exposure and supply disruption. The emphasis throughout is on actionable interpretation-connecting operational realities to commercial outcomes-so decision-makers can apply the findings to portfolio, sourcing, and go-to-market choices with confidence.

Conclusion: Yiqing Keli Rewards Brands That Combine Tradition with Modern Quality Systems, Localized Execution, and Tariff-Ready Resilience

Yiqing Keli is evolving into a more demanding, more professionalized arena where quality signals, compliance discipline, and consumer experience define competitive advantage. As buyers become more informed and channels become more selective, companies can no longer rely on tradition alone; they must deliver consistent performance, explain value clearly, and maintain documentation that supports trust.

At the same time, 2025 tariff pressure in the United States is acting as a catalyst for structural improvement. It is pushing firms to modernize sourcing strategies, streamline portfolios, and invest in operational controls that protect continuity. Those that respond with systemic changes rather than short-term pricing tactics will be better positioned to withstand volatility and capture share when competitors falter.

Across segmentation and regions, the strongest opportunities favor organizations that match format and messaging to real use-cases, localize responsibly, and build omnichannel readiness without fragmenting quality. With disciplined execution, Yiqing Keli can serve as a durable platform for brand trust and repeat demand in a wellness landscape that increasingly rewards credibility and consistency.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Yiqing Keli Market, by Product Formulation
8.1. Standard Granule
8.1.1. Sugar-Coated Granule
8.1.2. Sugar-Free Granule
8.2. Pediatric Granule
8.2.1. Low-Dose Pediatric Granule
8.2.2. Standard Pediatric Granule
8.3. Capsule
8.3.1. Hard Capsule
8.3.2. Soft Capsule
8.4. Oral Solution
8.4.1. Ready-to-Drink Solution
8.4.2. Concentrated Solution
9. Yiqing Keli Market, by Dosage Strength
9.1. Low Strength
9.2. Standard Strength
9.3. High Strength
9.4. Titrated Dose Packs
10. Yiqing Keli Market, by Indication Category
10.1. Upper Respiratory Tract Infection
10.1.1. Common Cold
10.1.2. Acute Pharyngitis
10.1.3. Acute Tonsillitis
10.2. Influenza-Like Illness
10.2.1. Seasonal Influenza
10.2.2. Viral Fever
10.3. Lower Respiratory Complications
10.3.1. Acute Bronchitis
10.3.2. Exacerbation of Chronic Bronchitis
10.4. Preventive Use
10.4.1. Immunity Support
10.4.2. Post-Exposure Prophylaxis
11. Yiqing Keli Market, by End User
11.1. Hospitals
11.2. Clinics
11.2.1. General Practitioner Clinics
11.2.2. ENT Clinics
11.2.3. TCM Clinics
11.3. Home Use
12. Yiqing Keli Market, by Distribution Channel
12.1. Hospital Pharmacies
12.2. Retail Pharmacies
12.3. Traditional Medicine Clinics
12.4. Online Pharmacies
13. Yiqing Keli Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Yiqing Keli Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Yiqing Keli Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Yiqing Keli Market
17. China Yiqing Keli Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Anguo Yadong Biopharmaceutical Co., Ltd.
18.6. Guangdong Luofushan National Pharmaceutical Co., Ltd.
18.7. Guizhou Hengba Pharmaceutical Co., Ltd.
18.8. Jiangxi Huiren Pharmaceutical Co., Ltd.
18.9. Jiangxi Xinglin Baima Pharmaceutical Co., Ltd.
18.10. Jilin Gaomiao Pharmaceutical Co., Ltd.
18.11. Mengyang Pharmaceutical Co., Ltd.
18.12. Qionglai Tianyin Pharmaceutical Co., Ltd.
18.13. Shanxi Jinxin Shuanghe Pharmaceutical Co., Ltd.
18.14. Tonghua Hongbao Pharmaceutical Co., Ltd.
18.15. Tonghua Jinkaiwei Pharmaceutical Co., Ltd.
18.16. Tonghua Jinma Pharmaceutical Group Co., Ltd.
18.17. Yunnan Xitao Green Pharmaceutical Co., Ltd.
18.18. Zhejiang Weikang Pharmaceutical Co., Ltd.
List of Figures
FIGURE 1. GLOBAL YIQING KELI MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL YIQING KELI MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL YIQING KELI MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL YIQING KELI MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL YIQING KELI MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL YIQING KELI MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL YIQING KELI MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES YIQING KELI MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA YIQING KELI MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL YIQING KELI MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL YIQING KELI MARKET SIZE, BY STANDARD GRANULE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL YIQING KELI MARKET SIZE, BY STANDARD GRANULE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL YIQING KELI MARKET SIZE, BY STANDARD GRANULE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL YIQING KELI MARKET SIZE, BY SUGAR-COATED GRANULE, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL YIQING KELI MARKET SIZE, BY SUGAR-COATED GRANULE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL YIQING KELI MARKET SIZE, BY SUGAR-COATED GRANULE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL YIQING KELI MARKET SIZE, BY SUGAR-FREE GRANULE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL YIQING KELI MARKET SIZE, BY SUGAR-FREE GRANULE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL YIQING KELI MARKET SIZE, BY SUGAR-FREE GRANULE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL YIQING KELI MARKET SIZE, BY LOW-DOSE PEDIATRIC GRANULE, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL YIQING KELI MARKET SIZE, BY LOW-DOSE PEDIATRIC GRANULE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL YIQING KELI MARKET SIZE, BY LOW-DOSE PEDIATRIC GRANULE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL YIQING KELI MARKET SIZE, BY STANDARD PEDIATRIC GRANULE, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL YIQING KELI MARKET SIZE, BY STANDARD PEDIATRIC GRANULE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL YIQING KELI MARKET SIZE, BY STANDARD PEDIATRIC GRANULE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL YIQING KELI MARKET SIZE, BY CAPSULE, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL YIQING KELI MARKET SIZE, BY CAPSULE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL YIQING KELI MARKET SIZE, BY CAPSULE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL YIQING KELI MARKET SIZE, BY HARD CAPSULE, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL YIQING KELI MARKET SIZE, BY HARD CAPSULE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL YIQING KELI MARKET SIZE, BY HARD CAPSULE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL YIQING KELI MARKET SIZE, BY SOFT CAPSULE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL YIQING KELI MARKET SIZE, BY SOFT CAPSULE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL YIQING KELI MARKET SIZE, BY SOFT CAPSULE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL YIQING KELI MARKET SIZE, BY ORAL SOLUTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL YIQING KELI MARKET SIZE, BY ORAL SOLUTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL YIQING KELI MARKET SIZE, BY ORAL SOLUTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL YIQING KELI MARKET SIZE, BY READY-TO-DRINK SOLUTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL YIQING KELI MARKET SIZE, BY READY-TO-DRINK SOLUTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL YIQING KELI MARKET SIZE, BY READY-TO-DRINK SOLUTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL YIQING KELI MARKET SIZE, BY CONCENTRATED SOLUTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL YIQING KELI MARKET SIZE, BY CONCENTRATED SOLUTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL YIQING KELI MARKET SIZE, BY CONCENTRATED SOLUTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL YIQING KELI MARKET SIZE, BY LOW STRENGTH, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL YIQING KELI MARKET SIZE, BY LOW STRENGTH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL YIQING KELI MARKET SIZE, BY LOW STRENGTH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL YIQING KELI MARKET SIZE, BY STANDARD STRENGTH, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL YIQING KELI MARKET SIZE, BY STANDARD STRENGTH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL YIQING KELI MARKET SIZE, BY STANDARD STRENGTH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL YIQING KELI MARKET SIZE, BY HIGH STRENGTH, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL YIQING KELI MARKET SIZE, BY HIGH STRENGTH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL YIQING KELI MARKET SIZE, BY HIGH STRENGTH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL YIQING KELI MARKET SIZE, BY TITRATED DOSE PACKS, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL YIQING KELI MARKET SIZE, BY TITRATED DOSE PACKS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL YIQING KELI MARKET SIZE, BY TITRATED DOSE PACKS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL YIQING KELI MARKET SIZE, BY COMMON COLD, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL YIQING KELI MARKET SIZE, BY COMMON COLD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL YIQING KELI MARKET SIZE, BY COMMON COLD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL YIQING KELI MARKET SIZE, BY ACUTE PHARYNGITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL YIQING KELI MARKET SIZE, BY ACUTE PHARYNGITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL YIQING KELI MARKET SIZE, BY ACUTE PHARYNGITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL YIQING KELI MARKET SIZE, BY ACUTE TONSILLITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL YIQING KELI MARKET SIZE, BY ACUTE TONSILLITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL YIQING KELI MARKET SIZE, BY ACUTE TONSILLITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL YIQING KELI MARKET SIZE, BY SEASONAL INFLUENZA, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL YIQING KELI MARKET SIZE, BY SEASONAL INFLUENZA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL YIQING KELI MARKET SIZE, BY SEASONAL INFLUENZA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL YIQING KELI MARKET SIZE, BY VIRAL FEVER, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL YIQING KELI MARKET SIZE, BY VIRAL FEVER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL YIQING KELI MARKET SIZE, BY VIRAL FEVER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL YIQING KELI MARKET SIZE, BY ACUTE BRONCHITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL YIQING KELI MARKET SIZE, BY ACUTE BRONCHITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL YIQING KELI MARKET SIZE, BY ACUTE BRONCHITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL YIQING KELI MARKET SIZE, BY EXACERBATION OF CHRONIC BRONCHITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL YIQING KELI MARKET SIZE, BY EXACERBATION OF CHRONIC BRONCHITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL YIQING KELI MARKET SIZE, BY EXACERBATION OF CHRONIC BRONCHITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL YIQING KELI MARKET SIZE, BY PREVENTIVE USE, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL YIQING KELI MARKET SIZE, BY PREVENTIVE USE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL YIQING KELI MARKET SIZE, BY PREVENTIVE USE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL YIQING KELI MARKET SIZE, BY IMMUNITY SUPPORT, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL YIQING KELI MARKET SIZE, BY IMMUNITY SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL YIQING KELI MARKET SIZE, BY IMMUNITY SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL YIQING KELI MARKET SIZE, BY POST-EXPOSURE PROPHYLAXIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL YIQING KELI MARKET SIZE, BY POST-EXPOSURE PROPHYLAXIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL YIQING KELI MARKET SIZE, BY POST-EXPOSURE PROPHYLAXIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL YIQING KELI MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL YIQING KELI MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL YIQING KELI MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL YIQING KELI MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL YIQING KELI MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL YIQING KELI MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL YIQING KELI MARKET SIZE, BY GENERAL PRACTITIONER CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL YIQING KELI MARKET SIZE, BY GENERAL PRACTITIONER CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL YIQING KELI MARKET SIZE, BY GENERAL PRACTITIONER CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL YIQING KELI MARKET SIZE, BY ENT CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL YIQING KELI MARKET SIZE, BY ENT CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL YIQING KELI MARKET SIZE, BY ENT CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL YIQING KELI MARKET SIZE, BY TCM CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL YIQING KELI MARKET SIZE, BY TCM CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL YIQING KELI MARKET SIZE, BY TCM CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL YIQING KELI MARKET SIZE, BY HOME USE, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL YIQING KELI MARKET SIZE, BY HOME USE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL YIQING KELI MARKET SIZE, BY HOME USE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL YIQING KELI MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL YIQING KELI MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL YIQING KELI MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL YIQING KELI MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL YIQING KELI MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL YIQING KELI MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL YIQING KELI MARKET SIZE, BY TRADITIONAL MEDICINE CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL YIQING KELI MARKET SIZE, BY TRADITIONAL MEDICINE CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL YIQING KELI MARKET SIZE, BY TRADITIONAL MEDICINE CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL YIQING KELI MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL YIQING KELI MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL YIQING KELI MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL YIQING KELI MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 134. AMERICAS YIQING KELI MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 135. AMERICAS YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
TABLE 136. AMERICAS YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
TABLE 137. AMERICAS YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
TABLE 138. AMERICAS YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 139. AMERICAS YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
TABLE 140. AMERICAS YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
TABLE 141. AMERICAS YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
TABLE 142. AMERICAS YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
TABLE 143. AMERICAS YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
TABLE 144. AMERICAS YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
TABLE 145. AMERICAS YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
TABLE 146. AMERICAS YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 147. AMERICAS YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 148. AMERICAS YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 149. NORTH AMERICA YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. NORTH AMERICA YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
TABLE 151. NORTH AMERICA YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
TABLE 152. NORTH AMERICA YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
TABLE 153. NORTH AMERICA YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 154. NORTH AMERICA YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
TABLE 155. NORTH AMERICA YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
TABLE 156. NORTH AMERICA YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
TABLE 157. NORTH AMERICA YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
TABLE 158. NORTH AMERICA YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
TABLE 159. NORTH AMERICA YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
TABLE 160. NORTH AMERICA YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
TABLE 161. NORTH AMERICA YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 162. NORTH AMERICA YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 163. NORTH AMERICA YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 164. LATIN AMERICA YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 165. LATIN AMERICA YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
TABLE 166. LATIN AMERICA YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
TABLE 167. LATIN AMERICA YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
TABLE 168. LATIN AMERICA YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 169. LATIN AMERICA YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
TABLE 170. LATIN AMERICA YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
TABLE 171. LATIN AMERICA YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
TABLE 172. LATIN AMERICA YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
TABLE 173. LATIN AMERICA YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
TABLE 174. LATIN AMERICA YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
TABLE 175. LATIN AMERICA YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
TABLE 176. LATIN AMERICA YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 177. LATIN AMERICA YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 178. LATIN AMERICA YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 194. EUROPE YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 195. EUROPE YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
TABLE 196. EUROPE YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
TABLE 197. EUROPE YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
TABLE 198. EUROPE YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 199. EUROPE YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
TABLE 200. EUROPE YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
TABLE 201. EUROPE YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
TABLE 202. EUROPE YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
TABLE 203. EUROPE YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
TABLE 204. EUROPE YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
TABLE 205. EUROPE YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
TABLE 206. EUROPE YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 207. EUROPE YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 208. EUROPE YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 209. MIDDLE EAST YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 210. MIDDLE EAST YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
TABLE 211. MIDDLE EAST YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
TABLE 212. MIDDLE EAST YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
TABLE 213. MIDDLE EAST YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 214. MIDDLE EAST YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
TABLE 215. MIDDLE EAST YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
TABLE 216. MIDDLE EAST YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
TABLE 217. MIDDLE EAST YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
TABLE 218. MIDDLE EAST YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
TABLE 219. MIDDLE EAST YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
TABLE 220. MIDDLE EAST YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
TABLE 221. MIDDLE EAST YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 222. MIDDLE EAST YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 223. MIDDLE EAST YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 224. AFRICA YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 225. AFRICA YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
TABLE 226. AFRICA YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
TABLE 227. AFRICA YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
TABLE 228. AFRICA YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 229. AFRICA YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
TABLE 230. AFRICA YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
TABLE 231. AFRICA YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
TABLE 232. AFRICA YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
TABLE 233. AFRICA YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
TABLE 234. AFRICA YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
TABLE 235. AFRICA YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
TABLE 236. AFRICA YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 237. AFRICA YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 238. AFRICA YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 239. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 240. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
TABLE 241. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
TABLE 242. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
TABLE 243. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 244. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
TABLE 245. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
TABLE 246. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
TABLE 247. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
TABLE 248. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
TABLE 249. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
TABLE 250. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
TABLE 251. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 252. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 253. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 254. GLOBAL YIQING KELI MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 255. ASEAN YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 256. ASEAN YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
TABLE 257. ASEAN YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
TABLE 258. ASEAN YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
TABLE 259. ASEAN YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 260. ASEAN YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
TABLE 261. ASEAN YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
TABLE 262. ASEAN YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
TABLE 263. ASEAN YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
TABLE 264. ASEAN YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
TABLE 265. ASEAN YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
TABLE 266. ASEAN YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
TABLE 267. ASEAN YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 268. ASEAN YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 269. ASEAN YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 270. GCC YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 271. GCC YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
TABLE 272. GCC YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
TABLE 273. GCC YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
TABLE 274. GCC YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 275. GCC YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
TABLE 276. GCC YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
TABLE 277. GCC YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
TABLE 278. GCC YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
TABLE 279. GCC YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
TABLE 280. GCC YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
TABLE 281. GCC YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
TABLE 282. GCC YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 283. GCC YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 284. GCC YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 285. EUROPEAN UNION YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 286. EUROPEAN UNION YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
TABLE 287. EUROPEAN UNION YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
TABLE 288. EUROPEAN UNION YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
TABLE 289. EUROPEAN UNION YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 290. EUROPEAN UNION YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
TABLE 291. EUROPEAN UNION YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
TABLE 292. EUROPEAN UNION YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
TABLE 293. EUROPEAN UNION YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
TABLE 294. EUROPEAN UNION YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
TABLE 295. EUROPEAN UNION YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
TABLE 296. EUROPEAN UNION YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
TABLE 297. EUROPEAN UNION YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 298. EUROPEAN UNION YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 299. EUROPEAN UNION YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 300. BRICS YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 301. BRICS YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
TABLE 302. BRICS YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
TABLE 303. BRICS YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
TABLE 304. BRICS YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 305. BRICS YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
TABLE 306. BRICS YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
TABLE 307. BRICS YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
TABLE 308. BRICS YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
TABLE 309. BRICS YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
TABLE 310. BRICS YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
TABLE 311. BRICS YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
TABLE 312. BRICS YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 313. BRICS YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 314. BRICS YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 315. G7 YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 316. G7 YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
TABLE 317. G7 YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
TABLE 318. G7 YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
TABLE 319. G7 YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 320. G7 YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
TABLE 321. G7 YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
TABLE 322. G7 YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
TABLE 323. G7 YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
TABLE 324. G7 YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
TABLE 325. G7 YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
TABLE 326. G7 YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
TABLE 327. G7 YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 328. G7 YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 329. G7 YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 330. NATO YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 331. NATO YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
TABLE 332. NATO YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
TABLE 333. NATO YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
TABLE 334. NATO YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 335. NATO YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
TABLE 336. NATO YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
TABLE 337. NATO YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
TABLE 338. NATO YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
TABLE 339. NATO YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
TABLE 340. NATO YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
TABLE 341. NATO YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
TABLE 342. NATO YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 343. NATO YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 344. NATO YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 345. GLOBAL YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 346. UNITED STATES YIQING KELI MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 347. UNITED STATES YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
TABLE 348. UNITED STATES YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-20

Companies Mentioned

The key companies profiled in this Yiqing Keli market report include:
  • Anguo Yadong Biopharmaceutical Co., Ltd.
  • Guangdong Luofushan National Pharmaceutical Co., Ltd.
  • Guizhou Hengba Pharmaceutical Co., Ltd.
  • Jiangxi Huiren Pharmaceutical Co., Ltd.
  • Jiangxi Xinglin Baima Pharmaceutical Co., Ltd.
  • Jilin Gaomiao Pharmaceutical Co., Ltd.
  • Mengyang Pharmaceutical Co., Ltd.
  • Qionglai Tianyin Pharmaceutical Co., Ltd.
  • Shanxi Jinxin Shuanghe Pharmaceutical Co., Ltd.
  • Tonghua Hongbao Pharmaceutical Co., Ltd.
  • Tonghua Jinkaiwei Pharmaceutical Co., Ltd.
  • Tonghua Jinma Pharmaceutical Group Co., Ltd.
  • Yunnan Xitao Green Pharmaceutical Co., Ltd.
  • Zhejiang Weikang Pharmaceutical Co., Ltd.

Table Information